CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal...(and uncertainties including uncertaintie...)

Date:10/24/2008

and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to clinical studies, regulatory review and approval, and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the year ended June 30, 2008 as updated from time to time by our quarterly reports on Form 10-Q and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

'/>"/>

SOURCE Accuray Incorporated Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. First CyberKnife System Purchased in Latin America
2. Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology
3. St. Lukes Episcopal Hospital to Add CyberKnife System to Treatment Offerings
4. First CyberKnife System Sold in Switzerland
5. CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
6. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
7. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
8. Isis Ibis Biosciences Subsidiary Highlights the Power of the Ibis T5000 Pathogen Identification and Characterization System at the ICAAC/IDSA Meeting
9. LI-COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging
10. Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
11. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays